Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc (NQ: COSM )

1.570 -0.060 (-3.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cosmos Health Inc

< Previous 1 2 3 Next >
Cosmos Health Shares Surge 27%, Decoupling From A Decidedly Bearish Market ($COSM)
Via AB Newswire
Cosmos Health Posted A 202% Increase In Adjusted EBITDA In 1H/2022; Here’s Why 2H/2022 Is Expected To Be Even Better ($COSM)
Via AB Newswire
Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States
Via ACCESSWIRE
Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022
Via ACCESSWIRE
Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives
Via ACCESSWIRE
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board
Via ACCESSWIRE
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board
CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands
Via ACCESSWIRE
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands
CHICAGO, IL / ACCESSWIRE / July 20, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association
Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board
CHICAGO, IL / ACCESSWIRE / July 8, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome
Acquisition will include all launched and under development bone health products 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders
CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Exposures COVID-19
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States
First commercial launch of the Company's nutraceutical products in the U.S. follows successful launches on Amazon in other key markets 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022
Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022 CHICAGO, IL / ACCESSWIRE / May 18, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Cosmos Holdings, Inc.
Via AccessWire
Exposures COVID-19
Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021
CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line
New line contains unique formulations and ingredients found in specific regions in Greece and the Mediterranean CHICAGO, IL / ACCESSWIRE / April 12, 2022 / Cosmos Holdings, Inc. ("the Company")... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore
CHICAGO, IL / ACCESSWIRE / April 5, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health
Designed to support and enhance brain function CHICAGO, IL / ACCESSWIRE / March 31, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health
Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwide CHICAGO, IL / ACCESSWIRE / March 28, 2022 / Cosmos Holdings, Inc. ("the Company")... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
CHICAGO, IL / ACCESSWIRE / March 24, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings CEO Provides Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing
CHICAGO, IL / ACCESSWIRE / March 11, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.